Egypt’s PM inspects upgraded IV, pharma plants at El Nasr Chemicals

Egyptian Prime Minister Moustafa Madbouly on Saturday inspected two upgraded pharmaceutical production facilities during a visit to El Nasr Pharmaceutical Chemicals Company in Qalyubia Governorate, as part of broader efforts to boost domestic drug manufacturing.

The visit included a tour of the Solid Pharmaceutical Preparations factory and the Large-Volume Intravenous (IV) Solutions facility. Both are operated by El Nasr, a subsidiary of the Holding Company for Pharmaceuticals, Chemicals, and Medical Supplies, under the Ministry of Public Business Sector.

Yasser Fawzy, Executive Managing Director of El Nasr, said the solid dosage plant was rehabilitated between February and August 2024 at a cost of 20 million Egyptian pounds. Veterinary production lines were later added for 1 million pounds. The facility now produces 420 million tablets, 100 million hard capsules, and 2.8 million veterinary sachets annually.

Fawzy added that the IV solutions factory underwent a 25 million pound upgrade between February and September 2024. It now includes two high-tech filling machines, one of which is among only two of its kind in the Middle East. Annual output includes 18 million bottles and 8.4 million bags of large-volume IV solutions.

The upgrades are part of Egypt’s national push to localise pharmaceutical production and improve access to essential medical supplies.

Attribution: Amwal Al Ghad English